Introduction to Digital Therapeutics (DTx) in the Indian Context Technical Architecture for DTx Prescription and Delivery Data Interoperability and Integration Requirements Patient Onboarding and Prescriber Workflow Integration Current Indian Reimbursement Landscape for DTx Challenges in Health Insurance Policy Alignment Clinical Validation and Evidence Requirements for Reimbursement Regulatory Considerations and Prescription Authority Technical Gaps in Current Indian Healthcare IT Infrastructure Future Technical and Reimbursement Pathways Introduction to Digital Therapeutics (DTx) in the Indian Context Digital Therapeutics (DTx) represent a distinct category of healthcare interventions, driven by software to prevent, manage, or treat a medical disorder or disease. Their integration into clinical practice necessitates a robust technical framework for prescription, delivery, and monitoring. Within the Indian healthcare ecosystem, ...
Personalized Pharmacogenomics Integration: Global Data Platforms Informing Indian Drug Coverage Policy
The Imperative for Pharmacogenomic Data in Indian Drug Coverage Global Data Platform Architectures and Their Relevance Technical Integration Challenges for Indian Stakeholders Data Standardization and Interoperability Hurdles Informing Drug Coverage: Cost-Effectiveness and Clinical Utility Metrics Regulatory Frameworks and Data Governance in India Actionable Data for Policy Formulation: A Pragmatic Approach The Imperative for Pharmacogenomic Data in Indian Drug Coverage The current paradigms of drug coverage policy in India, as in many other global markets, are primarily driven by empirical evidence of efficacy and broad population-level safety data. This approach, while functional, inherently leads to suboptimal therapeutic outcomes for a significant segment of the patient population. Pharmacogenomics (PGx), the study of how genes affect a person's response to drugs, presents a critical dataset for enhancing precision in drug selection, dosage, and admi...